|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Siegel RL, Ward EM and Jemal A:
Global cancer incidence and mortality rates and trends-an update.
Cancer Epidemiol Biomarkers Prev. 25:16–27. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mayer RJ: Targeted therapy for advanced
colorectal cancer-more is not always better. N Engl J Med.
360:623–625. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Longley DB, Harkin DP and Johnston PG:
5-fluorouracil: Mechanisms of action and clinical strategies. Nat
Rev Cancer. 3:330–338. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Temraz S, Mukherji D, Alameddine R and
Shamseddine A: Methods of overcoming treatment resistance in
colorectal cancer. Crit Rev Oncol Hematol. 89:217–230. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yu R, Deedigan L, Albarenque SM, Mohr A
and Zwacka RM: Delivery of sTRAIL variants by MSCs in combination
with cytotoxic drug treatment leads to p53-independent enhanced
antitumor effects. Cell Death Dis. 4:e5032013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rich JN and Bao S: Chemotherapy and cancer
stem cells. Cell Stem Cell. 1:353–355. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tummers B and Green DR: Caspase-8:
Regulating life and death. Immunol Rev. 277:76–89. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Estaquier J, Vallette F, Vayssiere JL and
Mignotte B: The mitochondrial pathways of apoptosis. Adv Exp Med
Biol. 942:157–183. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Susin SA, Lorenzo HK, Zamzami N, Marzo I,
Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler
M, et al: Molecular characterization of mitochondrial
apoptosis-inducing factor. Nature. 397:441–446. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Azmi AS, Wang Z, Philip PA, Mohammad RM
and Sarkar FH: Emerging Bcl-2 inhibitors for the treatment of
cancer. Expert Opin Emerg Drugs. 16:59–70. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shakibaei M, Mobasheri A, Lueders C, Busch
F, Shayan P and Goel A: Curcumin enhances the effect of
chemotherapy against colorectal cancer cells by inhibition of NF-κB
and Src protein kinase signaling pathways. PLoS One. 8:e572182013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Douillard JY, Sobrero A, Carnaghi C,
Comella P, Díaz-Rubio E, Santoro A and Van Cutsem E: Metastatic
colorectal cancer: Integrating irinotecan into combination and
sequential chemotherapy. Ann Oncol. 14 Suppl 2:ii7–ii12. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Giacchetti S, Perpoint B, Zidani R, Le
Bail N, Faggiuolo R, Focan C, Chollet P, Llory JF, Letourneau Y,
Coudert B, et al: Phase III multicenter randomized trial of
oxaliplatin added to chronomodulated fluorouracil-leucovorin as
first-line treatment of metastatic colorectal cancer. J Clin Oncol.
18:136–147. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu CX, Nan KJ and Lei Y: Agents from
amphibians with anticancer properties. Anticancer Drugs.
19:931–939. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Miao Q, Bi LL, Li X, Miao S, Zhang J,
Zhang S, Yang Q, Xie YH, Zhang J and Wang SW: Anticancer effects of
bufalin on human hepatocellular carcinoma HepG2 cells: Roles of
apoptosis and autophagy. Int J Mol Sci. 14:1370–1382. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xie CM, Chan WY, Yu S, Zhao J and Cheng
CH: Bufalin induces autophagy-mediated cell death in human colon
cancer cells through reactive oxygen species generation and JNK
activation. Free Radic Biol Med. 51:1365–1375. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Santandreu FM, Valle A, Oliver J and Roca
P: Resveratrol potentiates the cytotoxic oxidative stress induced
by chemotherapy in human colon cancer cells. Cell Physiol Biochem.
28:219–228. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fishbein AB, Wang CZ, Li XL, Mehendale SR,
Sun S, Aung HH and Yuan CS: Asian ginseng enhances the
anti-proliferative effect of 5-fluorouracil on human colorectal
cancer: Comparison between white and red ginseng. Arch Pharm Res.
32:505–513. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jiang L, Zhao MN, Liu TY, Wu XS, Weng H,
Ding Q, Shu YJ, Bao RF, Li ML, Mu JS, et al: Bufalin induces cell
cycle arrest and apoptosis in gallbladder carcinoma cells. Tumour
Biol. 35:10931–10941. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Qiu DZ, Zhang ZJ, Wu WZ and Yang YK:
Bufalin, a component in Chansu, inhibits proliferation and invasion
of hepatocellular carcinoma cells. BMC Complement Altern Med.
13:1852013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Takai N, Ueda T, Nishida M, Nasu K and
Narahara H: Bufalin induces growth inhibition, cell cycle arrest
and apoptosis in human endometrial and ovarian cancer cells. Int J
Mol Med. 21:637–643. 2008.PubMed/NCBI
|
|
23
|
Chang Y, Zhao Y, Gu W, Cao Y, Wang S, Pang
J and Shi Y: Bufalin inhibits the differentiation and proliferation
of cancer stem cells derived from primary osteosarcoma cells
through Mir-148a. Cell Physiol Biochem. 36:1186–1196. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao L, Liu S, Che X, Hou K, Ma Y, Li C,
Wen T, Fan Y, Hu X, Liu Y and Qu X: Bufalin inhibits TGF-β-induced
epithelial-to-mesenchymal transition and migration in human lung
cancer A549 cells by downregulating TGF-β receptors. Int J Mol Med.
36:645–652. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sampath D, Rao VA and Plunkett W:
Mechanisms of apoptosis induction by nucleoside analogs. Oncogene.
22:9063–9074. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hong SH and Choi YH: Bufalin induces
apoptosis through activation of both the intrinsic and extrinsic
pathways in human bladder cancer cells. Oncol Rep. 27:114–120.
2012.PubMed/NCBI
|
|
27
|
Datta SR, Katsov A, Hu L, Petros A, Fesik
SW, Yaffe MB and Greenberg ME: 14-3-3 proteins and survival kinases
cooperate to inactivate BAD by BH3 domain phosphorylation. Mol
Cell. 6:41–51. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Qu Y, Xia P, Zhang S, Pan S and Zhao J:
Silencing XIAP suppresses osteosarcoma cell growth, and enhances
the sensitivity of osteosarcoma cells to doxorubicin and cisplatin.
Oncol Rep. 33:1177–1184. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mehrotra S, Languino LR, Raskett CM,
Mercurio AM, Dohi T and Altieri DC: IAP regulation of metastasis.
Cancer Cell. 17:53–64. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Qi F, Li A, Inagaki Y, Kokudo N, Tamura S,
Nakata M and Tang W: Antitumor activity of extracts and compounds
from the skin of the toad Bufo bufo gargarizans Cantor. Int
Immunopharmacol. 11:342–349. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Meng Z, Yang P, Shen Y, Bei W, Zhang Y, Ge
Y, Newman RA, Cohen L, Liu L, Thornton B, et al: Pilot study of
huachansu in patients with hepatocellular carcinoma, nonsmall-cell
lung cancer, or pancreatic cancer. Cancer. 115:5309–5318. 2009.
View Article : Google Scholar : PubMed/NCBI
|
